Gyre Pharmaceuticals Chairman Luo Ying Honored in 2024 Forbes China Most Influential Chinese Elite TOP 100 Selection
2024-11-11
Luo Ying, Chairman of Gyre Pharmaceuticals, has been named to the prestigious 2024 Forbes ...
Milestone in Phase III Clinical Trial of Hydronidone (F351) of Gyre Pharmaceuticals
2024-10-23
Gyre Pharmaceuticals (also known as Beijing Continent Pharmaceuticals) announced the succe...
Study on Pirfenidone for Treating Radiation-Induced Lung Injury Shined at ASTRO 2024
2024-10-18
From September 29 to October 2, 2024, the 66th Annual Meeting of the American Society for ...